influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (propiolactone inactivated), influenza a virus a/darwin/6/2021 ivr-227 (h3n2) antigen (propiolactone inactivated), influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated), and influenza b virus b/phuket/3073/2013 bvr-1b antigen (propiolactone inactivated)
influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (propiolactone inactivated), influenza a virus a/darwin/6/2021 ivr-227 (h3n2) antigen (propiolactone inactivated), influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated), and influenza b virus b/phuket/3073/2013 bvr-1b antigen (propiolactone inactivated) · INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL · Injection, Solution · Patheon Manufacturing Services LLC
NDC 63552-0192-00 · 10 SYRINGE, GLASS in 1 CARTON / .5 mL in 1 SYRINGE, GLASS · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (propiolactone inactivated), influenza a virus a/darwin/6/2021 ivr-227 (h3n2) antigen (propiolactone inactivated), influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated), and influenza b virus b/phuket/3073/2013 bvr-1b antigen (propiolactone inactivated) (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Patheon Manufacturing Services LLC | INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL | Jul 22, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED) 15 ug/.5mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (propiolactone inactivated), influenza a virus a/darwin/6/2021 ivr-227 (h3n2) antigen (propiolactone inactivated), influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated), and influenza b virus b/phuket/3073/2013 bvr-1b antigen (propiolactone inactivated) — NDC 63552-0192-00," retrieved September 3, 2026, https://drugdashboards.com/drug/63552019200.
Free to cite with attribution — see how the data is put together.